The SLC31A1 gene helps move copper from food into cells, where this mineral supports energy production, brain function, and healthy tissues. This gene plays an important role in keeping copper balanced, so if it does not work well, cells may not get enough copper and can struggle to do their normal jobs. Depending on the variant, this may contribute to problems with growth, development, nerve function, or other organs. The SLC31A1 gene can also influence how some platinum based cancer medicines enter cells.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can learn more in the LearnHub.
Overview
SLC31A1Gene function
What if the gene works
The SLC31A1 gene helps move copper into cells. This copper supports enzymes your body uses for energy, brain function, and building connective tissue.
Risk
What if the gene does not work
Variants in the SLC31A1 gene can reduce how well cells bring copper inside. Milder variants may partly lower copper uptake, while more severe variants can markedly disrupt copper delivery to enzymes that need it.
Treatment
What does that mean for your treatment
No SLC31A1-specific treatment or management approach is currently established. The SLC31A1 gene is being studied as a biomarker of response to platinum chemotherapy and as a possible drug target in cancer and copper biology research.
Gene function
What if the gene works
Your cells need a steady supply of copper, a trace mineral that helps many enzymes do their jobs. The SLC31A1 gene gives instructions for a transport protein that moves copper from outside the cell to the inside. Understanding how the SLC31A1 gene works in the body helps explain how cells keep this essential mineral in balance.
The SLC31A1 gene helps copper move from outside the cell to the inside. This gives your cells access to a trace mineral they need for everyday work.
Copper delivered through this pathway is used by enzymes, which are helper proteins in cells. These enzymes support energy production and protection from routine cell stress.
Cells can adjust how much of this transporter sits on their surface. That helps copper levels stay in a useful range instead of drifting too low or too high.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SLC31A1 gene can alter how its copper transporter is folded, how stable it is, or whether it reaches the cell surface, which may reduce copper entry into cells. Milder variants may partly lower transporter activity, while more severe variants can keep the protein from working at all or lead to early breakdown. This range helps explain how SLC31A1 variants affect copper transport, from small shifts in uptake to near-complete loss of cellular entry.
How variants are linked to conditions
SLC31A1 does not yet have a broadly confirmed link to a specific inherited health condition, although research on conditions linked to SLC31A1 gene variants is still developing. If you carry a reported variant in the SLC31A1 gene, its meaning is usually interpreted alongside your symptoms, family history, and other test results by a doctor or genetic counselor.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC31A1 gene. If a change in SLC31A1 is found on testing, a doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
Inheritance of SLC31A1 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of SLC31A1 gene variants tied to a specific human condition, and this picture may become clearer as research develops. The SLC31A1 gene is located on chromosome 9, which is an autosome. That means everyone inherits one copy of the SLC31A1 gene from each parent. In general, variants in genes on autosomes can be passed from either parent to sons or daughters.
What does my SLC31A1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the SLC31A1 gene, although this can become clearer as research grows. If you have a specific SLC31A1 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact variant found.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the SLC31A1 gene, clinicians use genetic testing, usually on a blood, saliva, or cheek swab sample. SLC31A1 genetic testing reads the DNA code to check for changes in this gene and may be done on its own or as part of a larger gene panel.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC31A1-specific reason for genetic testing in routine care. Decisions about testing are best made with a doctor or genetic counselor, based on your health history and any patterns in your family.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains varies based on the condition and the specific type of variant. Many other factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best viewed together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly, while another may absorb less of it or be more sensitive to its effects. These common differences can influence how well a treatment works and how likely side effects are, which is why the same medication can feel quite different from one person to another.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This understanding can support treatment decisions that are both more informed and more individualized. To learn more about this topic, more detail is available in the LearnHub.
Drugs influenced by the SLC31A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so medication questions or side effects are best discussed with your doctor. Research on the SLC31A1 gene has looked at how people respond to platinum-based cancer drugs, but this has not become routine care.
History
SLC31A1 entered human genetics in the late 1990s, when researchers identified it as the human counterpart of a copper transport gene first studied in yeast. Initially understood through cell and animal experiments, later recognized as tied to a specific gene, it helped connect basic copper research with human biology. From these first observations, research expanded steadily as scientists mapped the gene, described its activity in different tissues, and explored how changes in its expression related to disease. Interest in SLC31A1 also grew through cancer research, especially studies looking at how cells take up platinum based chemotherapy drugs. While it has not become a public facing gene in the way BRCA1 or APOE have, it remains an important part of the scientific story of metal transport and treatment response.